Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
Compare Profit and Loss Results of Novartis India
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
451.00
-95.00
-21.06%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
451.00
-95.00
-21.06%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
0.00
3.00
0%
Raw Materials Consumed
199.00
223.00
-24.00
-10.76%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
18.00
59.00
-41.00
-69.49%
Operating Expenses
8.00
6.00
2.00
33.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
77.00
-67.00
-87.01%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
4.00
5.00
125.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
393.00
-129.00
-32.82%
Operating Profit (PBDIT) excl Other Income
91.00
58.00
33.00
56.90%
Other Income
41.00
17.00
24.00
141.18%
Operating Profit (PBDIT)
133.00
75.00
58.00
77.33%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
132.00
75.00
57.00
76.00%
Depreciation
2.00
6.00
-4.00
-66.67%
Profit Before Taxation & Exceptional Items
130.00
69.00
61.00
88.41%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
69.00
61.00
88.41%
Provision for Tax
29.00
18.00
11.00
61.11%
Profit After Tax
100.00
50.00
50.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
236.00
492.00
208.47%
Profit Available for appropriations
829.00
287.00
542.00
188.85%
Appropriations
829.00
287.00
542.00
188.85%
Equity Dividend (%)
500%
460%
40.00
Earnings Per Share
40.87
17.58
23.29
132.48%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024






